Showing 6491-6500 of 7526 results for "".
- Brooke Shields Takes on New Role as Celebrity Spokesperson for SculpSure Body Contouringhttps://practicaldermatology.com/news/brooke-shields-take-on-new-role-as-celebrity-spokesperson-for-sculpsure-body-contouring/2460005/Actress, model, Broadway star, and author Brooke Shields will serve as national spokesperson for Hologic’s Cynosure's SculpSure body contouring laser treatment. As the face of SculpSure’s new “Be strong. Be sexy. Be confident.” campaign, Ms. Shields will inspire consum
- Fibrocell to Collaborate with Castle Creek Pharmaceuticals to Develop and Commercialize RDEB Gene Therapyhttps://practicaldermatology.com/news/fibrocell-to-collaborate-with-castle-creek-pharmaceuticals-to-develop-and-commercialize-rdeb-gene-therapy/2460004/Fibrocell Science, Inc. has entered into a collaboration agreement with Castle Creek Pharmaceuticals to develop and commercialize Fibrocell’s lead gene therapy candidate, FCX-007, for the treatment of recessive dystrophic epidermolysis bullosa (RDEB), a rare, life-threatening genetic disord
- L'Oreal To Support Reconstruction of Notre Dame Cathedralhttps://practicaldermatology.com/news/loreal-to-support-reconstruction-of-notre-dame-cathedral/2460003/The Bettencourt Meyers family and the L’Oréal Group are making a joint donation of 100 million euros toward the “renaissance” of the Notre-Dame Cathedral, which they describe as a symbol of French heritage and common history.
- Industry Vet Linda Esposito Named New CFO at Skyn ICELANDhttps://practicaldermatology.com/news/industry-vet-linda-esposito-named-new-cfo-at-skyn-iceland/2460002/Linda Esposito is the new Chief Financial Officer at Skyn ICELAND, a privately held New York-based skin care company. Ms. Esposito will report to Founder and Chief Executive Officer Sarah Kugelman and will oversee all financial aspects of t
- Maine Gets SUNucatedhttps://practicaldermatology.com/news/maine-gets-sunucated/2460001/Maine is joining 19 other states in allowing students to possess and use sunscreen in school. Governor Janet Mills signed LD 441, which was sponsored by Senator Cathy Breen. Modeled after American Society for Dermatologic Surgery Association’s (ASDSA) SUNucate legislation, the bil
- National Psoriasis Foundation Elects New Leaders to Board of Directorshttps://practicaldermatology.com/news/national-psoriasis-foundation-elects-new-leaders-to-board-of-directors/2459993/To recognize their dedication in helping people with psoriasis and psoriatic arthritis as volunteers, members, and donors, the National Psoriasis Foundation (NPF) elected Jerry Bagel MD, MS of East Windsor, NJ, Mike Refermat of San Diego, CA, and Jodi Wood
- Derm Students Improve Wikipedia Entries on Skin Disease, Boost Viewshttps://practicaldermatology.com/news/derm-students-improve-wikipedia-entries-on-skin-disease-boost-views-1/2459992/A group of medical students recruited to improve Wikipedia articles on skin-related diseases and saw millions more views of those stories following their editing, a new study shows. "We tried to make the articles more readable, while adding more relevant information," say
- PALLAS Ti: Sapphire Solid State Laser Shows Similar Efficacy and Safety to 308nm Excimer Laser for Localized Vitiligohttps://practicaldermatology.com/news/pallas-tisapphire-solid-state-laser-shows-similar-efficacy-and-safety-to-308nm-excimer-laser-for-localized-vitiligo/2459953/A novel 311nm Titanium:Sapphire UV laser demonstrates comparable efficacy and safety when compared to 308nm excimer laser in the treatment of localized vitiligo, according to a study recently published in Lasers in Surgery and Medicine. Manufactured by
- Cutera Hosts Beauty Talk with Sadick and Sadickhttps://practicaldermatology.com/news/cuter-hosts-beauty-talk-with-sadick-and-sadick/2459960/Dermatologist Neil Sadick, MD and his daughter Sydney Sadick, an in-the-know fashion journalist, talked about everything from state-of-the-art skin brightening treatments to the newest injectables and how to get svelte without sweating or surgery at
- Lead Pharma Begins Phase I Trials with SAR441169 Candidate Treatment for Psoriasishttps://practicaldermatology.com/news/lead-pharma-to-begin-phase-i-trials-with-sar441169-candidate-treatment-for-psoriasis/2459962/Lead Pharma, a pharmaceutical company developing innovative medicines for the treatment of immunological and oncological indications, achieved a fourth milestone under its license & collaboration agreement with Sanofi, triggering an undisclosed milestone payment. The milestone payment is link